# US 8,278,289 B2 · Boroxine composition for removal of skin changes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,289 B2
- Document ID: US8278289B2
- Status: Granted
- Kind: B2
- Application number: 12/294,017
- Filed: 2006-03-21
- Published: 2009-09-24
- Granted: 2012-10-02
- Earliest claimed: 2006-03-21
- Inventors: Borivoj Galic
- Web page: https://patentgrep.com/patent/US8278289B2

## CPC

- A61K 31/69: Boron compounds
- A61K 8/58: containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A61P 17/00: Drugs for dermatological disorders
- A61Q 19/00: Preparations for care of the skin
- C01B 35/12: Borates {(C01B35/1063 takes precedence)}
- A61K 2800/58: Metal complex; Coordination compounds
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- C01B: NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; {METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C}

## Abstract

The present invention relates to the field of skin disorders, particularly to the prevention and/or treatment of benignant or malignant changes of the epidermis visible in form of e.g. nevus. A pharmaceutical, dermatological and/or cosmetic composition is disclosed comprising as active constituent the boroxine compound. The present invention further provides the respective uses of the boroxine compound in medicine, particularly in the field of skin disorders, and in dermatological and/or cosmetic applications.

## Claims

### Claim 1

A topical pharmaceutical composition comprising:
(a) a boroxine compound, which has the formula:
wherein
R1, R2, R3, R4 and R5 are independently from each other OH or Halogen, wherein at least one of R1, R2, R3, R4 and R5 is Halogen; and
X+ and Y+ are independently from each other a univalent ion or together a bivalent ion; and
(b) a pharmaceutically, cosmetically or dermatologically acceptable carrier, wherein the composition is in the form of an ointment or cream.

### Claim 2 (depends on 1)

A single dosage form of the composition according to claim 1, wherein the boroxine compound is in an amount of 0.01 to 10 mg.

### Claim 3 (depends on 1)

The compound composition according to claim 1, wherein X+ and Y+ are independently K+ and/or Na+.

### Claim 4 (depends on 1)

The composition of claim 1, wherein
R1 is OH;
R2, R3, R4 and R5 are F; and
X+ and Y+ are each K+.
